AERAS/ IAVI – International AIDS Vaccine Initiative

AIDS 2016 – Durban, South Africa
Session Title: Vaccines are Needed to Conclusively End HIV/AIDS and TB
Monday 18 July, 08:00 – 10:00
Co-Chairs: Jacqueline Shea, Aeras, United States
Mark Feinberg, International AIDS Vaccine Initiative (IAVI), United States
Organizer:
Aeras, International AIDS Vaccine Initiative (IAVI)
Abstract
The urgency of the highly interrelated TB and HIV/AIDS epidemics has prompted calls for a rapid and robust scale-up of TB and HIV vaccine research efforts and close collaboration between TB and HIV vaccine development programs. Those at risk for TB and HIV need more choices in prevention to circumvent structural, societal and cultural factors that hinder access and adherence. This session will discuss the importance of vaccine development and deployment to conclusively end HIV/AIDS and TB; it will describe the progress already made, as well as the challenges faced, and the potential for enhanced collaboration between TB and HIV vaccine researchers and developers. This session is targeted to researchers, policymakers, healthcare providers, product developers, civil society, and other stakeholders interested in ending the TB and HIV/AIDS epidemics.